2/27
10:46 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
2/27
10:46 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
1/14
08:42 am
phat
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Medium
Report
Phathom Pharmaceuticals (NASDAQ:PHAT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.